Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)

Rebecca Hall, Mark G. Lebwohl, Andrew G. Bushmakin, Eric L. Simpson, Melinda J. Gooderham, Andreas Wollenberg, Adam Gater, Jane R. Wells, Joseph C. Cappelleri, Ming Ann Hsu, Jocelyn Papacharalambous, Elena Peeva, Anna M. Tallman, Weidong Zhang, Linda Chen

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors would like to publish an erratum to the above article. The Discussion section of the original publication previously said: Furthermore, PSAAD was developed tomeet regulatory guidance and —unlike POEM, Itch Numeric Rating Scale (v2.0), Skin Pain Numeric Rating Scale (v2.0b), and Peak Pruritus Numerical Rating Scale— to be included in product-labelling claims in the USA and Europe.

Original languageEnglish (US)
Pages (from-to)1449-1450
Number of pages2
JournalDermatology and Therapy
Volume11
Issue number4
DOIs
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)'. Together they form a unique fingerprint.

Cite this